30.67
price down icon1.95%   -0.6068
 
loading

Finanzdaten der Forte Biosciences Inc-Aktie (FBRX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - 1.314 -
Operating Expenses
58.76%
18.38
11.58 16.12 7.351 8.629
Operating Income/Loss
58.76%
-18.38
-11.58 -16.12 -7.351 -8.629
Income/Loss From Continuing Operations Before Tax
57.19%
-17.68
-11.25 -15.66 -7.155 -8.392
Income/Loss From Continuing Operations After Tax
57.19%
-17.68
-11.25 -15.66 -7.155 -8.392
Net Income/Loss
57.19%
-17.68
-11.25 -15.66 -7.155 -8.392
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Earnings Per Share
3.13%
-0.99
-0.96 -1.37 3.18 -4.54
Diluted Earnings Per Share
3.13%
-0.99
-0.96 -1.37 3.18 -4.54
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$53.66
price down icon 1.23%
$48.26
price down icon 0.93%
$101.32
price up icon 1.82%
$149.69
price down icon 1.95%
$142.69
price down icon 2.69%
ONC ONC
$319.40
price down icon 0.06%
Kapitalisierung:     |  Volumen (24h):